Literature DB >> 19797063

Uropathogenic Escherichia coli Suppresses the host inflammatory response via pathogenicity island genes sisA and sisB.

Amanda L Lloyd1, Sara N Smith, Kathryn A Eaton, Harry L T Mobley.   

Abstract

Extraintestinal pathogenic Escherichia coli can successfully colonize the urinary tract of the immunocompetent host. In part, this is accomplished by dampening the host immune response. Indeed, the sisA and sisB genes (shiA-like inflammation suppressor genes A and B) of uropathogenic E. coli strain CFT073, homologs of the Shigella flexneri SHI-2 pathogenicity island gene shiA, suppress the host inflammatory response. A double deletion mutant (DeltasisA DeltasisB) resulted in a hyperinflammatory phenotype in an experimental model of ascending urinary tract infection. The DeltasisA DeltasisB mutant not only caused significantly more inflammatory foci in the kidneys of CBA/J mice (P = 0.0399), but these lesions were also histologically more severe (P = 0.0477) than lesions observed in mice infected with wild-type CFT073. This hyperinflammatory phenotype could be suppressed to wild-type levels by in vivo complementation of the DeltasisA DeltasisB mutant with either the sisA or sisB gene in trans. The DeltasisA DeltasisB mutant was outcompeted by wild-type CFT073 during cochallenge infection in the bladder (P = 0.0295) at 48 h postinoculation (hpi). However, during cochallenge infections, we reasoned that wild-type CFT073 could partially complement the DeltasisA DeltasisB mutant. Consistent with this, the most significant colonization defect of the DeltasisA DeltasisB mutant in vivo was observed during independent challenge relative to wild-type CFT073, with attenuation of the mutant observed in the bladder (P < 0.0001) and kidneys (P = 0.0003) at 6 hpi. By 24 and 48 hpi, the DeltasisA DeltasisB mutant was no longer significantly attenuated in the bladder or kidneys, suggesting that the sisA and sisB genes may be important for suppressing the host immune response during the initial stages of infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19797063      PMCID: PMC2786477          DOI: 10.1128/IAI.00779-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  55 in total

Review 1.  Molecular Koch's postulates applied to microbial pathogenicity.

Authors:  S Falkow
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

2.  Asymptomatic bacteriuria in schoolgirls. II. Differences in escherichia coli causing asymptomatic bacteriuria.

Authors:  U Lindberg; L A Hanson; U Jodal; G Lidin-Janson; K Lincoln; S Olling
Journal:  Acta Paediatr Scand       Date:  1975-05

3.  Transcriptome of uropathogenic Escherichia coli during urinary tract infection.

Authors:  Jennifer A Snyder; Brian J Haugen; Eric L Buckles; C Virginia Lockatell; David E Johnson; Michael S Donnenberg; Rodney A Welch; Harry L T Mobley
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

4.  Uropathogenicity in rats and mice of Providencia stuartii from long-term catheterized patients.

Authors:  D E Johnson; C V Lockatell; M Hall-Craigs; H L Mobley; J W Warren
Journal:  J Urol       Date:  1987-09       Impact factor: 7.450

5.  Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes.

Authors:  F W Studier; B A Moffatt
Journal:  J Mol Biol       Date:  1986-05-05       Impact factor: 5.469

6.  Neutrophil recruitment and bacterial clearance correlated with LPS responsiveness in local gram-negative infection.

Authors:  R D Shahin; I Engberg; L Hagberg; C Svanborg Edén
Journal:  J Immunol       Date:  1987-05-15       Impact factor: 5.422

7.  Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine.

Authors:  W Kruis; P Fric; J Pokrotnieks; M Lukás; B Fixa; M Kascák; M A Kamm; J Weismueller; C Beglinger; M Stolte; C Wolff; J Schulze
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

8.  Genomic islands of uropathogenic Escherichia coli contribute to virulence.

Authors:  Amanda L Lloyd; Tiffany A Henderson; Patrick D Vigil; Harry L T Mobley
Journal:  J Bacteriol       Date:  2009-03-27       Impact factor: 3.490

9.  Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin.

Authors:  L Hagberg; I Engberg; R Freter; J Lam; S Olling; C Svanborg Edén
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

10.  Toll-like receptor 4 expression and cytokine responses in the human urinary tract mucosa.

Authors:  Patrik Samuelsson; Long Hang; Björn Wullt; Heikki Irjala; Catharina Svanborg
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

View more
  24 in total

1.  Identification of Escherichia coli genes associated with urinary tract infections.

Authors:  Bin-Hsu Mao; Yung-Fu Chang; Joy Scaria; Chih-Ching Chang; Li-Wei Chou; Ni Tien; Jiunn-Jong Wu; Chin-Chung Tseng; Ming-Cheng Wang; Chao-Chin Chang; Yuan-Man Hsu; Ching-Hao Teng
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

Review 2.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

Review 3.  Host-pathogen interactions in urinary tract infection.

Authors:  Greta R Nielubowicz; Harry L T Mobley
Journal:  Nat Rev Urol       Date:  2010-07-20       Impact factor: 14.432

4.  Escherichia coli CFT073 Fitness Factors during Urinary Tract Infection: Identification Using an Ordered Transposon Library.

Authors:  Allyson E Shea; Juan Marzoa; Stephanie D Himpsl; Sara N Smith; Lili Zhao; Lisa Tran; Harry L T Mobley
Journal:  Appl Environ Microbiol       Date:  2020-06-17       Impact factor: 4.792

5.  A Rare Opportunist, Morganella morganii, Decreases Severity of Polymicrobial Catheter-Associated Urinary Tract Infection.

Authors:  Brian S Learman; Aimee L Brauer; Kathryn A Eaton; Chelsie E Armbruster
Journal:  Infect Immun       Date:  2019-12-17       Impact factor: 3.441

6.  Genome-wide mapping of cystitis due to Streptococcus agalactiae and Escherichia coli in mice identifies a unique bladder transcriptome that signifies pathogen-specific antimicrobial defense against urinary tract infection.

Authors:  Chee K Tan; Alison J Carey; Xiangqin Cui; Richard I Webb; Deepak Ipe; Michael Crowley; Allan W Cripps; William H Benjamin; Kimberly B Ulett; Mark A Schembri; Glen C Ulett
Journal:  Infect Immun       Date:  2012-06-25       Impact factor: 3.441

7.  Proteus mirabilis fimbriae- and urease-dependent clusters assemble in an extracellular niche to initiate bladder stone formation.

Authors:  Jessica N Schaffer; Allison N Norsworthy; Tung-Tien Sun; Melanie M Pearson
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-04       Impact factor: 11.205

8.  The Pathogenic Potential of Proteus mirabilis Is Enhanced by Other Uropathogens during Polymicrobial Urinary Tract Infection.

Authors:  Chelsie E Armbruster; Sara N Smith; Alexandra O Johnson; Valerie DeOrnellas; Kathryn A Eaton; Alejandra Yep; Lona Mody; Weisheng Wu; Harry L T Mobley
Journal:  Infect Immun       Date:  2017-01-26       Impact factor: 3.441

9.  Prc contributes to Escherichia coli evasion of classical complement-mediated serum killing.

Authors:  Chin-Ya Wang; Shainn-Wei Wang; Wen-Chun Huang; Kwang Sik Kim; Nan-Shan Chang; Ying-Hsiang Wang; Meng-Hsing Wu; Ching-Hao Teng
Journal:  Infect Immun       Date:  2012-07-23       Impact factor: 3.441

Review 10.  Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.

Authors:  Valerie P O'Brien; Thomas J Hannan; Hailyn V Nielsen; Scott J Hultgren
Journal:  Microbiol Spectr       Date:  2016-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.